# Rituximab-Induced Hypogammaglobulinemia in Multiple Sclerosis

> **NCT04283747** · — · UNKNOWN · sponsor: **Mazandaran University of Medical Sciences** · enrollment: 170 (estimated)

## Conditions studied

- Multiple Sclerosis
- Hypogammaglobulinemia

## Interventions

- **DIAGNOSTIC_TEST:** Serum immunoglobulin titer

## Key facts

- **NCT ID:** NCT04283747
- **Lead sponsor:** Mazandaran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-28
- **Primary completion:** 2022-10
- **Final completion:** 2022-12
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2020-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04283747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04283747, "Rituximab-Induced Hypogammaglobulinemia in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04283747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*